Binding of extracellular ligands to G protein-coupled receptors (GPCRs) initiates transmembrane signaling by inducing conformational changes on the cytoplasmic receptor surface. Knowledge of this process provides a platform for the development of GPCRtargeting drugs. Here, using a site-specific Cy3 fluorescence probe in the human β 2 -adrenergic receptor (β 2 AR), we observed that individual receptor molecules in the native-like environment of phospholipid nanodiscs undergo spontaneous transitions between two distinct conformational states. These states are assigned to inactive and active-like receptor conformations. Individual receptor molecules in the apo form repeatedly sample both conformations, with a bias toward the inactive conformation. Experiments in the presence of drug ligands show that binding of the full agonist formoterol shifts the conformational distribution in favor of the active-like conformation, whereas binding of the inverse agonist ICI-118,551 favors the inactive conformation. Analysis of single-molecule dwell-time distributions for each state reveals that formoterol increases the frequency of activation transitions, while also reducing the frequency of deactivation events. In contrast, the inverse agonist increases the frequency of deactivation transitions. Our observations account for the high level of basal activity of this receptor and provide insights that help to rationalize, on the molecular level, the widely documented variability of the pharmacological efficacies among GPCR-targeting drugs.
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signal transduction mechanisms | agonists and inverse agonists | conformational polymorphism | single-molecule fluorescence spectroscopy | phospholipid nanodiscs G protein-coupled receptors (GPCRs) mediate a multitude of physiological functions and are the targets for a myriad of drugs (1), many of which elicit different functional outcomes through the same receptor (2) . It remains to be rationalized at the molecular level why some drugs stimulate the signaling activity of a GPCR (full or partial agonists), whereas others either repress the receptor (inverse agonists) or have no effect on the intrinsic signaling activity (neutral antagonists). Moreover, the existence of a high basal activity of some GPCRs (3) suggests that the conformational transitions leading to activation may occur spontaneously, even in the absence of ligands, which in turn raises questions about the mechanistic roles of GPCR ligands. Understanding the mechanisms and pathways of receptor activation or deactivation, and how these are linked to the binding of ligands with different chemical structures and pharmacological efficacies, will aid in design of new GPCR-targeted drugs with tailored pharmacological responses and fewer side effects. To attain these goals, new methods are required to visualize the conformational dynamics of GPCRs in the presence and absence of drugs.
The β 2 -adrenergic receptor (β 2 AR) has been extensively investigated in crystals (4, 5) , by NMR in solution (6) (7) (8) (9) (10) (11) , by bulk fluorescence spectroscopy in solution (12) (13) (14) and in cells (2) , by single-molecule fluorescence spectroscopy (15) (16) (17) , and by molecular dynamics simulations (18) . Despite the availability of highresolution crystal structures of β 2 AR in inactive (4) and active (5) conformations, it remains unknown how ligands regulate transitions between the two states and why β 2 AR exhibits a significant level of ligand-independent, basal signaling activity. To address these questions, we use single-molecule fluorescence spectroscopy to monitor activation-linked conformational transitions of individual receptor molecules in real time over extended time periods. Our results highlight the intrinsically dynamic character of β 2 AR and provide insights into the mechanism of receptor activation and the roles of β 2 AR ligands.
Results
To visualize individual human β 2 AR molecules, we labeled the receptor with a bright fluorescent dye (Cy3) and reconstituted the receptor in phospholipid nanodiscs, under conditions that favor incorporation of just a single receptor per nanodisc (19) . The receptor-nanodisc complexes were tethered to a quartz surface and monitored over time for an average period of 70 s by total internal reflection fluorescence (TIRF) microscopy (Fig. 1A) . The Cy3 label was attached to Cys265 near the cytoplasmic end of helix VI (Fig. 1B) . Comparison of crystal structures of β 2 AR in inactive (4) and active (5) states reveals that the cytoplasmic end of helix VI moves outward by 14 Å and rotates during receptor activation, a conformational change that is expected to alter the fluorophore Significance Activation of G protein-coupled receptors (GPCRs) by agonists is the first step of eukaryotic cellular signal transduction. Because GPCRs are expressed in almost all human tissues and play a key role in human physiology, they are the targets for more than 30% of pharmaceutical drugs. Binding of ligands on the extracellular surface of a GPCR induces a conformational change on the cytoplasmic surface, which is recognized by G proteins or other cellular effectors. Here we show that the β 2 -adrenergic receptor, a prototypical GPCR, naturally fluctuates between inactive and active conformations, and that agonist or inverse agonist ligands modulate the conformational exchange kinetics in distinct ways, explaining their different pharmacological efficacies. These insights should assist in the design of improved GPCR-targeting drugs. environment (Fig. 1B) . Using a radioligand binding assay, we found that the Cy3-labeled receptor reconstituted in nanodiscs is fully functional in ligand binding (Fig. S1 ). The K d value for the radioligand [ (Table S1 ) is similar to that reported for native β 2 AR in membranes (20) , confirming that the nanodisc environment preserves the functionality of the receptor and that the receptor mutations required for site-specific labeling and the attached Cy3 label do not disrupt ligand binding. Control experiments confirmed that the receptor-nanodisc complexes were specifically bound to the surface and that individual complexes contained just one labeled receptor molecule, as intended ( Fig. S2 A-C) . A small fraction of receptor-nanodisc aggregates were also present on the surface, but these were readily identified by their high fluorescence intensity (Fig. S2A ) and were excluded from further analysis.
Fluorescence time trajectories from a collection of individual apo β 2 AR molecules were recorded simultaneously. Most trajectories reveal abrupt transitions between two distinct intensity states (three examples are shown in Fig. 2 ), whereas ∼30% of the trajectories exhibit relatively constant fluorescence intensity ( Fig.   S2D and Table S2 ). These static trajectories may represent a population of inactive receptors, consistent with a previous report that β 2 AR reconstituted in nanodiscs retained ∼60% of the starting activity (21) . The static receptor population was excluded from further analysis. The state of higher fluorescence intensity in the fluctuating trajectories likely arises from protein-induced fluorescence enhancement (PIFE) of Cy3 (22, 23) . Accordingly, for each single molecule, we normalized the fluorescence intensities at each time point to the mean intensity of the lower intensity state (Fig. 2) . A histogram compiled from 94 individual apo receptors reveals two distinct peaks, with relative areas of 31 and 69% (Fig.  3A) . The occurrence of two distinct peaks is analogous to fluorine NMR spectra recorded with a 19 F label attached to Cys265 of β 2 AR, and the relative peak areas are also similar (8) . As we explain below, the high-intensity state can be assigned to an inactive conformation of helix VI (state I), whereas the low-intensity state likely represents an active-like conformation (state A).
We next fitted the set of trajectories using hidden Markov modeling, allowing for two intensity states, and constructed a 2D plot of transition probability density (24) . The prominent cross-peaks reflect frequent transitions between states I and A (Fig. S3A) . To determine whether additional states were present, the trajectories were refitted, allowing for three intensity states, and the transition probability density plot was recalculated. The resulting plot revealed the same two major cross-peaks and no additional prominent features (Fig.  S3B) , indicating that the majority of intensity jumps observed across all datasets are adequately represented by transitions between two states with distinct fluorescence intensities (states I and A).
Individual receptor molecules exhibited a range of dwell times in one state before transition to the other state (three examples are shown in Fig. 2 ). We compiled histograms of the dwell times in each state from the set of 94 receptor molecules (Fig. S4A) . For a stochastic system composed of two exchanging states, the dwell-time distributions of either state should be described by a single exponential function. However, the dwell-time histograms Table S3 ). The majority of transitions from state I to state A (84 ± 23%) occur with high frequency, described by a rate constant of 2.6 ± 0.4 s
, whereas the remaining transitions are less frequent, with a rate constant of 0.40 ± 0.04 s . Similarly, the majority of transitions from state A to state I (89 ± 18%) are described by a rate constant of 4.2 ± 0.4 s
, whereas the remaining transitions are described by a rate constant of 0.58 ± 0.05 s −1 . It is unlikely that the second kinetic phase is due to a population of misfolded or otherwise defective receptors, because short dwell times (corresponding to the rapid phase) and very long dwell times (corresponding to the slow phase) are observed within the same molecule (Fig. 2) . Rather, it seems that state I consists of two kinetically distinct substates that share the same fluorescence intensity. The same argument applies to state A.
We then examined the effects of two prototypical β 2 AR ligands on the receptor's behavior, the full agonist formoterol (Form) and the inverse agonist ICI-118,551 (ICI), whose chemical structures are shown in Fig. S5 . Radioligand competition binding measurements showed that both ligands bind tightly to the receptor in nanodiscs (Fig. S6) , with K i values that are similar to the affinities reported for these ligands binding to β 2 AR on membranes (20, 25) , and that the Cy3 label does not perturb binding of either ligand (Table S1 ). Single-molecule fluorescence measurements performed in the presence of saturating concentrations (1 mM) of either ligand show that Cy3 fluctuates between the same two major intensity states that were observed in the apo form (Fig. 4 A and B) , indicating that the ligands do not induce new conformations at the probe location on helix VI. However, relative to the apo receptor, binding of Form shifted the equilibrium distribution toward state A (Fig. 3B ), whereas binding of ICI shifted the distribution toward state I (Fig. 3C) .
To gain further insights into the population shifts induced by these ligands, we analyzed the kinetics of conformational exchange between states I and A, in the presence of either Form or ICI. Dwell-time histograms of states I and A display biexponential kinetics in the presence of these ligands (Fig. S4 B and C) , as before, and the amplitudes of each phase are also similar to those observed in the apo form (Table S3) . However, relative to the apo receptor, transitions from state I to state A occur more frequently when Form is bound (Fig. 4C ) and deactivation transitions occur less frequently (Fig. 4D) . The major effect of ICI binding is to increase the frequency of deactivation transitions, evident in the slow kinetic phase (Fig. 4D) .
Discussion
Cy3 exhibits an enhanced fluorescence quantum yield when it is located in a protein environment, a phenomenon referred to as PIFE (22, 23) . Recently, it was shown that PIFE is specifically due to a reduction in excited-state cis-trans isomerization of Cy3, which normally competes with fluorescence emission (26) . Hence, the emission intensity of Cy3 is determined by the degree of steric restriction imposed on the fluorophore by the local environment: Highly restricted environments that inhibit cis-trans isomerization will produce relatively bright emission, whereas unrestricted environments that permit isomerization will lead to relatively weak emission. We constructed a model of the Cy3-β 2 AR conjugate based on the crystal structure of β 2 AR in an inactive conformation (bound to inverse agonist; ref. 4) and determined the most likely location of the Cy3 moiety after 10 6 rounds of Monte Carlo energy minimization. The resulting model shows that Cy3 lies in a channel surrounded by helices III, IV, and V (Fig. 5A) , an environment that is expected to restrict cis-trans isomerization. Accordingly, the state of higher fluorescence intensity (state I) likely corresponds to an inactive conformation of helix VI. In contrast, a model of the Cy3-β 2 AR conjugate based on the crystal structure of β 2 AR in an active conformation (bound to agonist and G protein; ref. 5) shows that the Cy3 moiety is fully solventexposed and free to undergo facile cis-trans isomerization (Fig. 5B) . Hence, the low-intensity state (state A) likely corresponds to an active or active-like conformation of helix VI. The fluorescence intensity of Cy3 in state I is approximately twofold higher than in state A, reflecting a significant PIFE effect (22) . It should be noted that the assignments of the states I and A are fully consistent with the observed effects of the β 2 AR ligands. The full agonist Form shifts the conformational distribution in favor of state A, whereas the inverse agonist ICI shifts the balance toward state I (Fig. 3) . Indeed, Form and ICI are known to favor active and inactive functional states of β 2 AR, respectively (20, 27) .
The active-like receptor conformation was the major species (73%) populated in the presence of the full agonist Form, although a significant population of the inactive conformation remained (Fig. 3B) . These observations are consistent with previous studies showing that binding of a full agonist to β 2 AR does not produce a homogeneous population of active-like receptor conformations (7, 8, 11) . Notably, our results are in close agreement with a previous fluorine NMR study using a 19 F label attached to Cys265 of β 2 AR, which showed that ∼60% of receptors occupied an active-like conformation in the presence of Form (8) .
The kinetic information obtained from dwell-time analysis of the single-molecule trajectories is consistent with previous estimates of the conformational exchange rates or activation times of β 2 AR and also reveals previously unidentified kinetic properties of β 2 AR. Fluorine NMR saturation transfer experiments have established an upper limit of 10 s −1 for the overall rate of exchange between inactive and active-like conformations of β 2 AR (10), which is consistent with our estimates of the rate constants for transitions between states I and A in the apo receptor (based on the data in Table S3 , the total exchange rates are 6.8 ± 0.9 s −1 and 0.98 ± 0.09 s −1 for the fast and slow kinetic phases, respectively). Another study based on a 19 F-NMR probe attached to Cys265 reported a lifetime of 660 ms for an agonistbound state of β 2 AR (11), which is consistent with our estimate of the rate constant (rapid component) for the deactivation transition of helix VI in the presence of Form (Fig. 4D) . A fluorescence-based (FRET) study using a β 2 AR construct fused to CFP and YFP reporter proteins revealed activation times of 48 ms or 128 ms in intact cells perfused with epinephrine or norepinephrine agonists, respectively (2). For comparison, we used the rate constants of the fast kinetic phase (Table S3) to calculate the time required to establish an equilibrium distribution of states I and A after addition of the full agonist Form to the apo receptor. The resulting value of 128 ± 18 ms is similar to the activation times measured in intact cells, confirming that the nanodiscs used in our experiments provide a native-like environment for the receptor. In addition to the rapid conformational transitions, which are in accord with previous studies, our singlemolecule observations also reveal that helix VI spends prolonged periods in either the inactive or active-like conformation. These long dwell times are readily evident in the fluorescence trajectories of individual receptors (Figs. 2 and 4) and give rise to a long tail in the dwell-time histograms compiled from a population of receptors (Fig. S4) , necessitating the use of a biexponential function for best fit (Table S3 ). The long periods in either conformation have not been observed before. We speculate that as helix VI initially adopts an active-like conformation, additional interactions are formed within the receptor core, without any change in fluorophore emission intensity, further stabilizing this conformation and giving rise to the long dwell times in the low-intensity state (state A). Similarly, we speculate that the long dwell times in the high-intensity state (state I) are due to the formation of additional stabilizing interactions while helix VI is in the inactive conformation.
Our results clearly show that β 2 AR in the apo form (i.e., in the absence of either agonist ligands or G proteins) can spontaneously transition between inactive and active-like conformations. In fact, the active-like conformation of helix VI is significantly populated under these conditions (Fig. 3A) . In the cellular context, where G proteins are present, our results imply that the receptor can access the active conformation and initiate a signaling response in the absence of extracellular ligand binding. In fact, β 2 AR exhibits a significant level of ligand-independent (basal) signaling activity (27) . In addition, the results of our study also provide insights into the mechanisms by which ligands regulate the signaling activity of β 2 AR. The full agonist Form increases the frequency of activation transitions and also reduces the frequency of deactivation transitions (Fig. 4 C and D) , both of which are expected to enhance signaling activity. In contrast, the inverse agonist ICI increases the frequency of deactivation transitions (Fig. 4D) , explaining why this ligand reduces signaling activity. Overall, our results show that agonist and inverse agonist ligands regulate the signaling activity of β 2 AR by fine-tuning the kinetics of transitions between two intrinsic receptor conformations. In a related study, individual detergent-solubilized β 2 AR molecules labeled with tetramethylrhodamine at Cy265 were observed in solution while confined in an electrokinetic trap (17) . A broad distribution of fluorescence intensity states with dwell times in the millisecond time range were observed. In contrast, we have observed slower transitions between two discrete intensity states and presented strong evidence that these correspond to inactive and active-like conformations of β 2 AR. Our ability to detect spontaneous transitions between two intrinsic receptor conformations is likely due to the unique photophysical properties of Cy3, the nativelike environment of the phospholipid nanodiscs, and the relatively long time scale of our observations. Recently, single-molecule fluorescence spectroscopy was used to visualize conformational transitions in the extracellular ligand-binding domain of the metabotropic glutamate receptor, either as an isolated protein dimer (28) or as part of the full-length receptor (29) . In contrast, our observations of β 2 AR in nanodiscs reveal the dynamics of the membrane-embedded region of a GPCR.
Single-molecule fluorescence (SMF) spectroscopy in nanodiscs complements and significantly extends the insights available from other biophysical approaches. Similar to 19 F NMR spectroscopy (8), SMF analysis is able to resolve inactive and active-like receptor conformations and to quantify their relative populations in the presence or absence of drug ligands. However, SMF is the only technique capable of directly visualizing spontaneous transitions between these receptor conformations in real time. Moreover, whereas 19 F NMR saturation transfer experiments have established an upper limit for the overall rate of exchange between inactive and active-like conformations of β 2 AR (10), dwell-time analysis of the two fluorescence intensity states observed by SMF can determine rate constants for the individual conformational transitions. The resulting kinetic information provides previously unidentified insights, showing that the full agonist Form affects both the activation and deactivations steps, whereas the inverse agonist ICI primarily affects deactivation (Fig. 4 C and D) . Understanding the specific effects of drug ligands on the activation/deactivation processes in the molecular detail described here can be expected to provide new opportunities for improved design of GPCR-targeting drugs. Moreover, we can now use these advances in SMF spectroscopy of GPCRs in nanodiscs to explore how interactions with G proteins and/or addition of specific membrane components influence receptor activation.
Materials and Methods
Expression and Purification of Cy3-Labeled β 2 AR. The human β 2 AR construct used in this study has been described previously (8) . The construct contains the thermostabilizing E122W mutation (25) , is truncated at residue 348, and a portion of intracellular loop 3 (ICL3) not required for G protein binding (residues 245-249) is removed. For simplicity, this construct is referred to here as WT. It has been shown that only three cysteine residues within this construct (Cys265, Cys327, and Cys341) are available for labeling with sulfhydryl-reactive reagents (8) . The construct used for site-specific fluorophore labeling, referred to as the C265 construct, also contains C327S and C341A mutations. All receptor constructs were expressed in Sf9 cells and extracted as described (8) , before incubating with cobalt-based immobilized metal affinity chromatography beads (Talon) overnight. The receptor-loaded Talon beads were washed extensively with wash buffer 1 [50 mM Hepes (pH 7.5), 150 mM NaCl, 5 mM MgCl 2 , 1 mM n-dodecyl-β-D-maltoside (DDM), 0.2 mM cholesteryl hemisuccinate (CHEMS), 20 mM imidazole, and 8 mM ATP] and wash buffer 2 [50 mM Hepes (pH 7.5), 150 mM NaCl, 1 mM DDM, 0.2 mM CHS, and 20 mM imidazole) and then exchanged into 10 mL labeling buffer [50 mM Hepes (pH 7.5), 150 mM NaCl, 1 mM DDM, and 0.2 mM CHS]. A 10-fold molar excess of Cy3 maleimide (GE Healthcare) (20 μL of a 5 mg·mL −1 solution in DMSO) was then added and the reaction mixture incubated in the dark for 1 h. After Cy3 labeling, β 2 AR was further purified using the standard protocol (8) .
Nanodisc Preparation. Biobeads were added to a mixture of labeled β 2 AR, membrane scaffold protein 1 (MSP1), and phospholipids (1:10:700) in cholate buffer, following the reconstitution procedure described previously (30) . The phospholipid mixture contained POPC, POPS, and biotinyl CAP PE (67.5:27.5:5%) (Avanti Polar Lipids). The receptor, MSP1, and lipid mixture was incubated overnight at 4°C, after which the biobeads were removed and the nanodisc-receptor complex was purified by size-exclusion chromatography. The reconstituted receptor-nanodisc complexes were further separated from empty nanodiscs by purifying His-tag-containing complexes using Talon columns. Single-Molecule Fluorescence Measurements. Single-molecule data collection was performed using an inverted Axiovert 200 microscope (Zeiss) modified for prism-based TIRF imaging (TIRF Labs Inc.) under oxygen-scavenging conditions, as described (31, 32) . Quartz slides were cleaned, passivated with polyethylene glycol, and coated with streptavidin, as described (33) . Biotin conjugated receptor-nanodisc complexes in imaging buffer [50 mM Hepes (pH 7.5), 150 mM NaCl, and 2 mM trolox] were introduced into the sample chamber and allowed to bind to the streptavidin-coated surface, after which unbound nanodiscs were washed away and the imaging buffer was enriched with glucose oxidase and catalase as an oxygen scavenging system was introduced. Immobilized nanodisc-receptor complexes were excited using a green laser (532 nm) and the Cy3 emission intensity was recorded over time on an intensified CCD camera (Andor Technology) with a 100-ms frame time. Binary complexes were formed by incubating a saturating concentration (1 mM) of a desired ligand with the receptor on the slide surface before excitation and data recording. All measurements were performed at 298 K. A custom-written single-molecule data acquisition package was used in combination with IDL software (ITT VIS, version 8.1) to record CCD camera data and generate fluorescence intensity time traces.
Single-Molecule Data Analysis. Trajectories displaying reversible intensity fluctuations before a single-step photobleaching event were selected for analysis. Each selected emission intensity trajectory was corrected for background, smoothed by three-point sliding averaging, and truncated before photobleaching. Binned fluorescence intensity histograms were compiled from multiple trajectories and fitted with two Gaussian functions using Igor Pro software (version 6; Wavemetrics). Individual trajectories were fitted with a hidden Markov model using the program HaMMy (24) . All trajectories were fitted adequately with two distinct intensity states. The intensity levels observed before and after each transition were assigned to state I or state A, based on a chosen threshold value. The dwell times spent in each state before transition to the other state were compiled in the form of histograms, using data from multiple individual receptor molecules. The resulting histograms were fitted with both single and double exponential functions to determine the rate constant(s) for the corresponding conformational transition and the associated uncertainty in the rate constant(s) using Igor Pro software. The quality of the resulting fits was judged from the reduced χ 2 values. The data points were weighted according to their variance (square root of the observed value).
Modeling of the Fluorescent Dye-Receptor Conjugates. Energy-based conformational modeling of Cy3-β 2 AR conjugates was performed using the ICM molecular modeling suite (Molsoft, LLC). Modeling of the inactive state was based on the crystal structure of the β 2 AR complex with inverse agonist carazolol (PDB ID code 2RH1). After removal of the T4 lysozyme fusion in intracellular loop 3, the conformation of Cys265 was modeled by extension of the α-helical conformation in helix VI for residues Lys263-Lys267. The α-helical conformation at these residue positions is supported by previous observations of this conformation in other β 2 AR structures in both active and inactive states (PDB ID codes 3SN6 and 4GBR), as well as in several structures of the closely related β 1 AR receptor (e.g., PDB ID code 4AMJ). The activestate model was based on the crystal structure of β 2 AR complex with agonist BI-167107 and G protein heterotrimer (PDB ID code 3SN6). The Cy3 dye molecule was built and conjugated to the corresponding cysteine thiol moiety in both models, with its covalent geometry optimized using the MMFF force field. The conformation of the conjugated dye was thoroughly sampled using more than 10 6 steps of a Monte Carlo minimization procedure in internal coordinates, and assuming flexibility of all side chains at the intracellular interface. For both inactive and active states, the lowest energy conformation of the Cy3 dye as well as all nonredundant conformations within 4 kJ/mol from the lowest energy conformation were collected (Fig. 5 ).
